These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
418 related items for PubMed ID: 12296406
1. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients. Bussaratid V, Tansupasawasdikul S, Simpson A, Pitisuttithum P, Phonrat B, Howe P, White NJ. J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406 [Abstract] [Full Text] [Related]
2. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C, Manteaux A, Millon L, Reboux G, Barale T, Laurent R. Ann Dermatol Venereol; 1996 Jul; 123(2):85-9. PubMed ID: 8761757 [Abstract] [Full Text] [Related]
3. [Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection]. Masiá Canuto MM, Gutiérrez Rodero F, Ortiz de la Tabla Ducasse V, Martín González C, Escolano Hortelano CM, Mora Rufete A, Martín Hidalgo A. Med Clin (Barc); 1999 Feb 20; 112(6):211-4. PubMed ID: 10191483 [Abstract] [Full Text] [Related]
4. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients. Kennedy HF, Shankland GS, Bagg J, Chalmers EA, Gibson BE, Williams CL. Mycoses; 2006 Nov 20; 49(6):457-62. PubMed ID: 17022761 [Abstract] [Full Text] [Related]
6. [Oesophageal candidiasis: clinical and mycological analysis]. Olmos MA, Araya V, Concetti H, Ramallo J, Piskorz E, Pérez H, Cahn P, Kaufman S, Guelfand L. Acta Gastroenterol Latinoam; 2005 Nov 20; 35(4):211-8. PubMed ID: 16496852 [Abstract] [Full Text] [Related]
7. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR. Indian J Pathol Microbiol; 2009 Nov 20; 52(4):501-4. PubMed ID: 19805956 [Abstract] [Full Text] [Related]
8. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C, González P, Pereira A, Pérez J, Noriega LM, Palavecino E. Rev Med Chil; 2003 May 20; 131(5):515-9. PubMed ID: 12879812 [Abstract] [Full Text] [Related]
10. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS. Southeast Asian J Trop Med Public Health; 2008 May 20; 39(3):492-5. PubMed ID: 18564689 [Abstract] [Full Text] [Related]
11. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. J Clin Microbiol; 2002 Sep 20; 40(9):3135-9. PubMed ID: 12202543 [Abstract] [Full Text] [Related]
12. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. Maninder J, Usha A. J Commun Dis; 2008 Sep 20; 40(3):177-81. PubMed ID: 19245155 [Abstract] [Full Text] [Related]
13. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA. J Clin Microbiol; 2006 Feb 20; 44(2):324-6. PubMed ID: 16455878 [Abstract] [Full Text] [Related]
14. Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana. Kwamin F, Nartey NO, Codjoe FS, Newman MJ. J Infect Dev Ctries; 2013 Jan 15; 7(1):41-5. PubMed ID: 23324819 [Abstract] [Full Text] [Related]
15. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients. Tekeli A, Koyuncu E, Dolapci I, Guven GS, Sahin GO, Uzun O. Mycoses; 2005 May 15; 48(3):197-201. PubMed ID: 15842337 [Abstract] [Full Text] [Related]
16. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R. Clin Infect Dis; 2006 Apr 15; 42(8):1179-86. PubMed ID: 16575739 [Abstract] [Full Text] [Related]
17. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients]. Dieng Y, Faye-Niang MA, Ndour-Diop A, Sow PS, Dieng T, Soumare M, Bah IB, Faye O, Diop BM, Gaye O, Ndir O, Diallo S. Dakar Med; 2001 Apr 15; 46(1):4-7. PubMed ID: 15773146 [Abstract] [Full Text] [Related]
18. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, AIDS Clinical Trials Group Study Team 323, Mycoses Study Group Study Team 40. Clin Infect Dis; 2005 Nov 15; 41(10):1473-80. PubMed ID: 16231260 [Abstract] [Full Text] [Related]
19. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N. Diabetes Care; 2007 Feb 15; 30(2):312-7. PubMed ID: 17259500 [Abstract] [Full Text] [Related]
20. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, Adeiga A. Afr Health Sci; 2008 Sep 15; 8(3):142-8. PubMed ID: 19357740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]